Ferritin Peptide Arraying on Chromium Tungsten Substrates

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional methods for selectively arraying ferritin or inorganic particles on silicon substrates with chromium, molybdenum, or tungsten portions require electrostatic interaction and specific coupling agents, limiting their density and selectivity, especially since peptides like RKLPDA have affinities only to titanium, silicon, and silver, not to elements like gold, chromium, platinum, tin, zinc, copper, and iron.

Innovation Solution

A method involving ferritin modified with a specific peptide at the N-terminal and a nonionic surfactant, which is applied to a silicon oxide substrate with chromium, molybdenum, or tungsten portions, allowing selective binding and subsequent heat treatment to decompose ferritin and leave inorganic particles arrayed at these metal portions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If electrostatic interaction is used for arraying ferritin on silicon substrates with chromium, molybdenum, or tungsten portions, then arraying can be achieved, but the density and selectivity are limited

Engineering Contradiction:
Improvearraying selectivityVSAvoidferritin density
Core Design Contradiction:
Manufacturing precisionVSQuantity of substance

Solution Approach 1:

The patent introduces a peptide (RKLPDA) as an intermediary molecule that mediates between ferritin and the metal substrate. This peptide has specific affinity for chromium, molybdenum, and tungsten surfaces, enabling selective binding of ferritin to these metal portions while overcoming the limitations of direct electrostatic interaction methods.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent modifies the surface properties of ferritin by attaching the peptide RKLPDA to its N-terminal. This parameter change in ferritin's surface characteristics enables selective interaction with metal substrates, achieving both high density and selectivity in arraying ferritin at chromium, molybdenum, or tungsten portions.

Inventive Principle:
Principle #35Parameter changes

2Adaptability or versatility

If peptide RKLPDA is used to modify ferritin surface, then affinity to titanium, silicon, and silver is imparted, but affinity to chromium, molybdenum, tungsten, gold, platinum, tin, zinc, copper, and iron is not achieved

Engineering Contradiction:
Improvesubstrate affinityVSAvoidselective arraying capability
Core Design Contradiction:
Adaptability or versatilityVSManufacturing precision

Solution Approach 1:

The patent applies the peptide RKLPDA specifically to the N-terminal region of ferritin, creating a localized modification that provides selective affinity. This local quality change enables ferritin to distinguish between different substrate types and bind selectively to chromium, molybdenum, and tungsten while avoiding non-specific binding to other metals.

Inventive Principle:
Principle #3Local quality

3Ease of operation

If nonionic surfactant is used to weaken protein-substrate interaction, then selective array on hydrophobic surfaces is enabled, but mechanism of occurrence on hydrophilic substrates remains unclear

Engineering Contradiction:
Improveselective arrayingVSAvoidmechanism understanding
Core Design Contradiction:
Ease of operationVSDevice complexity

Solution Approach 1:

The patent uses nonionic surfactant as an intermediary that mediates between the hydrophilic substrate and ferritin. The surfactant adsorbs onto the hydrophilic substrate surface, creating a protective layer that prevents direct interaction between ferritin and the substrate, thereby enabling selective arraying while providing a clear mechanism for hydrophilic surfaces.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables high-density, selective arraying of ferritin and inorganic particles at chromium, molybdenum, or tungsten portions on silicon oxide substrates, overcoming the limitations of existing methods by achieving precise control over particle placement and density.

Implementation Method 1

modification of a ferritin surface with a peptide consisting of six amino acids (arginine-lysine-leucine-proline-aspartic acid-alanine: hereinafter, denoted as RKLPDA in terms of one letter code) selected so as to provide an affinity to titanium

Methodology Applied
Scientific EffectAdsorption: Adsorption

Implementation Method 2

interaction with the solid surface is weakened using a nonionic surfactant to permit selective array on a titanium pattern

Methodology Applied
Scientific EffectSurfactant action: Surfactant

Implementation Method 3

subsequent heat treatment to decompose ferritin and leave inorganic particles arrayed at these metal portions

Methodology Applied
Scientific EffectThermal decomposition: Pyrolysis

Data Source

PatentUS9090711B2Method of arraying ferritin
Publication Date: 2015.07.28 PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO LTD
  • US9090711B2 patent drawing
  • US9090711B2 patent drawing
  • US9090711B2 patent drawing

AI summary

A method of selectively arraying ferritin and inorganic particles on a silicon oxide substrate having a chromium, niobium or tungsten portion. An aspect of the method includes steps of: preparing a solution which contains ferritin modified at an N-terminal part of a subunit with a peptide set out in SEQ ID NO: 1, and a nonionic surfactant; and a binding step of bringing the solution in contact with the silicon oxide substrate to selectively array peptide-modified ferritin to the chromium, niobium or, tungsten portion. Another aspect of the method includes selectively arraying ferritin modified with the peptide set out in SEQ ID NO: 1, and the inorganic particles contained in ferritin at the chromium, niobium, or tungsten portion by removing the solution.